華控康泰(01312.HK)盈警:預期2022財年淨虧約4320萬港元至6480萬港元
格隆匯3月6日丨華控康泰(01312.HK)公吿,預期集團於2022財政年度錄得綜合虧損淨額約4320萬港元至6480萬港元,而截至2021年12月31日止年度則錄得綜合虧損淨額約460萬港元。
上述變動主要來自集團的持續經營業務,具體歸因於下列因素:(i)集團醫藥業務因拓展市場需要,2022財政年度分銷及銷售費用較去年增加;(ii)集團健身業務於2022財政年度收取疫情相關政府補助及津貼較去年減少;(iii)集團健身業務於2022財政年度的應收款項預期信貸虧損較去年增加;及(iv)集團於2021財政年度出售一間附屬公司錄得一次性收益約5140萬港元。
儘管如此,集團於2022財政年度的持續經營業務的收入及毛利均有所增加,其主要原因是(i)集團醫藥業務於2022年財政年度並無經歷一名主要產品供應商無法按時交付生產材料的情況,而集團於2021年財政年度曾經歷有關無法按時交付而對其於該期間的銷售構成負面影響;(ii)集團健身業務逐漸擺脱疫情影響而有所改善。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.